Home ›
Trademark Categories ›
Medical Apparatus ›
2018 ›
GE ›
GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION MG PER ML (10 MG/ML)
Trademark search for:
GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION MG PER ML (10 MG/ML)
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2018-09-21 — Application filed
2018-09-25 — Application filed
2018-09-28 — Application filed
2018-09-29 — Notice of design search code e-mailed
2018-11-28 — Assigned to examiner
2018-11-29 — Examiners amendment -written
2018-11-29 — Examiners amendment e-mailed
2018-11-29 — Notification of examiners amendment e-mailed
2018-11-29 — Examiner's amendment entered
2018-11-30 — Approved for pub - principal register
2018-12-21 — Assigned to lie
2019-01-09 — Notification of notice of publication e-mailed
2019-01-29 — Published for opposition
2019-01-29 — Official gazette publication confirmation e-mailed
2019-03-26 — Noa e-mailed - sou required from applicant
2019-09-23 — Sou teas extension received
2019-09-23 — Sou extension 1 filed
2019-09-23 — Sou extension 1 granted
2019-09-25 — Notice of approval of extension request e-mailed
2020-03-24 — Sou teas extension received
2020-03-24 — Sou extension 2 filed
2020-03-24 — Sou extension 2 granted
2020-03-26 — Notice of approval of extension request e-mailed
2020-09-24 — Teas statement of use received
2020-09-24 — Sou teas extension received
2020-09-24 — Sou extension 3 filed
2020-09-24 — Use amendment filed
2020-09-30 — Case assigned to intent to use paralegal
2020-09-30 — Sou extension 3 granted
2020-09-30 — Statement of use processing complete
2020-10-01 — Notice of approval of extension request e-mailed
2020-10-22 — Final disposition recorded
2020-10-22 — Final disposition recorded
2020-10-22 — Final disposition recorded
2021-05-10 — Application abandoned
2021-05-10 — Application abandoned
2021-05-10 — Final status recorded
Owner Information
Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
Correspondent
Craig Kuchii, Esq. SUN PHARMACEUTICAL INDUSTRIES, INC.
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
